Global gene repression by the steroid receptor coactivator SRC-1 promotes oncogenesis

Cancer Research

Volumn 74, Issue 9, 2014, Pages 2533-2544

  Walsh, Claire A ^a   Bolger, Jarlath C ^a   Byrne, Christopher ^a   Cocchiglia, Sinead ^a   Hao, Yuan ^a,b   Fagan, Ailis ^a   Qin, Li ^c   Cahalin, Aoife ^a   McCartan, Damian ^a   McIlroy, Marie ^a   O'Gaora, Peadar ^b   Xu, Jianming ^c   Hill, Arnold D ^a   Young, Leonie S ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN; JUMONJI DOMAIN CONTAINING 2C; MEMBRANE PROTEIN; PROTEIN HOXC11; PROTEIN PAWR; STEROID RECEPTOR COACTIVATOR 1; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; BREAST CANCER; CANCER CELL; CARCINOGENESIS; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; ENZYME REPRESSION; GENE CONTROL; GENE REPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; ANTIGENS, CD24; APOPTOSIS REGULATORY PROTEINS; BINDING SITES; BREAST NEOPLASMS; CARCINOGENESIS; DISEASE-FREE SURVIVAL; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HOMEODOMAIN PROTEINS; HUMANS; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; KAPLAN-MEIER ESTIMATE; MCF-7 CELLS; MICE; MICE, KNOCKOUT; NUCLEAR RECEPTOR COACTIVATOR 1; PROMOTER REGIONS, GENETIC;

EID: 84900021697     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-2133     Document Type: Article

References (38)

1. Oñate SA, Tsai SY, Tsai MJ, O'Malley BW. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 1995;270:1354-7
2. Myers E, Hill AD, Kelly G, McDermott EW, O'Higgins NJ, Buggy Y, et al. Associations and Interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer. Clin Cancer Res 2005;11:2111-22 (Pubitemid 40490167)
3. Al-azawi D, Ilroy MM, Kelly G, Redmond AM, Bane FT, Cocchiglia S, et al. Ets-2 and p160 proteins collaborate to regulate c-Myc in endocrine resistant breast cancer. Oncogene 2008;27:3021-31 (Pubitemid 351668011)
4. McIlroy M, McCartan D, Early S,OGaora P, Pennington S, Hill AD, et al. Interaction of developmental transcription factor HOX11 with steroid receptor coactivator SRC-1 mediates resistance to endocrine therapy in breast cancer. Cancer Res 2010;70:1585-94
5. Voight BF, Kudaravalli S, Wen X, Pritchard JK. A map of recent positive selection in the human genome. PLoS Biol 2006;4:e72
6. O'Hara J, Vareslija D, McBryan J, Bane F, Tibbitts P, Byrne C, et al. AIB1:ERalpha transcriptional activity is selectively enhanced in AI-resistant breast cancer cells. Clin Cancer Res 2012;18:3305-15
7. McBryan J, Theissen SM, Byrne C, Hughes E, Cocchiglia S, Sande S, et al. Metastatic progression with resistance to aromatase inhibitors is driven by the steroid receptor coactivator SRC-1. Cancer Res 2012;72:548-59
8. Xu J,WuRC, O'Malley BW. Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat Rev Cancer 2009;9:615-30
9. Xu J, Qiu Y, DeMayo FJ, Tsai SY, Tsai MJ, O'Malley BW. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 1998;279:1922-5 (Pubitemid 28168645)
10. Qin L, Liu Z, Chen H, Xu J. The steroid receptor coactivator-1 regulates twist expression and promotes breast cancer metastasis. Cancer Res 2009;69:3819-27
11. McCartan D, Bolger JC, Fagan A, Byrne C, Hao Y, Qin L, et al. Global characterization of the SRC-1 transcriptome identifies ADAM22 as an ER-independent mediator of endocrine resistant breast cancer. Cancer Res 2012;72:220-9
12. Qin L, Chen X, Wu Y, Feng Z, He T, Wang L, et al. Steroid Receptor Coactivator-1 upregulates integrin alpha 5 expression to promote breast cancer cell adhesion and migration. Cancer Res 2011;71: 1742-51
13. Dobrovolna J, Chinenov Y, Kennedy MA, Liu B, Rogatsky I. Glucocorticoid- dependent phosphorylation of the transcriptional coregulator. Mol Cell Biol 2012;32:730-9
14. Uhlenhaut NH, Barish GD, Yu RT, Downes M, Karunasiri M, Liddle C, et al. Insights into negative regulation by the glucocorticoid receptor from genome-wide profiling of inflammatory cistromes. Mol Cell 2013;49;1-14
15. Bronzert DA, Greene GL, Lippman ME. Selection and characterization of a breast cancer cell line resistant to the antiestrogen LY 117018. Endocrinology 1985;117:1409-17 (Pubitemid 15238118)
16. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006;6:515-27 (Pubitemid 44854747)
17. Redmond AM, Bane FT, Stafford AT, McIlroy M, Dillon MF, Crotty TB, et al. Coassociation of estrogen receptor and p160 proteins predicts resistance to endocrine treatment; SRC-1 is an independent predictor of breast cancer recurrence. Clin Cancer Res 2009;15:2098-106
18. Dillon MF, Stafford AT, Kelly G, Redmond AM, McIlroy M, Crotty TB, et al. Cyclooxygenase-2 predicts adverse effects of tamoxifen: a possible mechanism of role for nuclear HER2 in breast cancer patients. Endocr Relat Cancer 2008;15:745-53
19. Berry L, Janknecht R. KDM4/JMJD2C histone demethylases: Epigenetic regulators in cancer cells. Cancer Res 2013;73:2936-42
20. Lizcano F, Romero C, Vargas D. Regulation of adipogenesis by nuclear receptor PPARg is modulated by the histone demethylase JMJD2C. Genet Mol Biol 2011;34:19-24
21. Mittelstadt ML, Patel RC. AP-1 mediated transcriptional repression of matrix metalloproteinase-9 by recruitment of histone deacetylase 1 in response to interferon β. PLoS One 2012;7:e42152
22. Xu L, Zhao Z, Dong A, Soubigou-Taconnat L, Renou JP, Steinmetz A, et al. Di- and tri- but not monomethylation on histone H3 lysine 36 marks active transcription of genes involved in flowering time regulation and other processes in Arabidopsis thaliana. Mol Cell Biol 2008;4:1348-60
23. Black JC, Van Rechem C, Whetstine Jr. Histone lysine methylation dynamics: establishment, regulation, and biological impact. Mol Cell 2012;4:491-507
24. Whetstine J, Nottke A, Lan F, Huarte M, Smolikov S, Chen Z, et al. Reversal of Histone Lysine Trimethylation by the JMJD2 Family of Histone Demethylases. Cell 2006;125:467-81
25. Thomas S, Harding MA, Smith SC, Overdevest JB, Nitz MD, Frierson HF, et al. CD24 is an effector of HIF-1-driven primary tumor growth and metastasis. Cancer Res 2012;21:5600-12
26. Cook J, Krishnan S, Ananth S, Sells SF, Shi Y, Walther MM, et al. Decreased expression of the pro-apoptotic protein Par-4 in renal cell carcinoma. Oncogene 1999;18:1205-8
27. Kögel D, Reimertz C, Mech P, Poppe M, Frühwald MC, Engemann H, et al. Dlk/ZIP kinase-induced apoptosis in human medulloblastoma cells: requirement of the mitochondrial apoptosis pathway. Br J Cancer 2001;85:1801-8 (Pubitemid 34081530)
28. Boehrer S, Chow KU, Puccetti E, Ruthardt M, Godzisard S, Krapohl A, et al. Deregulated expression of prostate apoptosis response gene-4 in less differentiated lymphocytes and inverse expressional patterns of par-4 and bcl-2 in acute lymphocytic leukemia. Hematol J 2001;2: 103-7 (Pubitemid 32427805)
29. Blick T, Hugo H, Widodo E, Waltham M, Pinto C, Mani SA, et al. Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer. J Mammary Gland Biol Neoplasia 2010;15: 235-52
30. Bieberich E, Silva J, Wang G, Krishnamurthy K, Condie BG. Selective apoptosis of pluripotent mouse and human stem cells by novel ceramide analogues prevents teratoma formation and enriches for neural precursors in ES cell-derived neural transplants. J Cell Biol 2004;167:723-34 (Pubitemid 39565152)
31. Rogatsky I, Luecke HF, Leitman DC, Yamamoto KR. Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts. Proc Natl Acad Sci U S A 2002;99:16701-6 (Pubitemid 36034036)
32. Rogatsky I, Zarember KA, Yamamoto KR. Factor recruitment and TIF2/ GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones. EMBO J 2001;20:6071-83 (Pubitemid 33049282)
33. Berdel B, Nieminen K, Soini Y, Tengström M, Malinen M, Kosma VM, et al. Histone demethylase GASC1-a potential prognostic and predictive marker in invasive breast cancer. BMC Cancer 2012;12:516
34. Luo W, Chang R, Zhong J, Pandey A, Semenza GL. Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression. Proc Natl Acad Sci USA 2012;109:E3367-76
35. Kashyap V, Ahmad S, Nilsson EM, Helczynski L, Kenna S, Persson JL, et al. The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer. Mol Oncol 2013;7: 555-66
36. Loh YH, Zhang W, Chen X, George J, Ng HH. Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells. Genes Dev 2007;21:2545-57 (Pubitemid 47607666)
37. Wissmann M, Yin N, Müller JM, Greschik H, Fodor BD, Jenuwein T, et al. Cooperative demethylation by JMJD2C and LSD1 promotes andogen receptor-dependent gene expression. Nat Cell Biol 2007; 9:347-53
38. Shi Y, Whetstine Jr. Dynamic regulation of histone lysine methylation by demethylases. Mol Cell 2007;25:1-14. (Pubitemid 46049067)